News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,116 Results
Type
Article (53117)
Company Profile (641)
Press Release (698358)
Section
Business (215828)
Career Advice (3198)
Deals (38174)
Drug Delivery (125)
Drug Development (85379)
Employer Resources (183)
FDA (17325)
Job Trends (16684)
News (367697)
Policy (35874)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2949)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (84)
Alliances (52589)
ALS (84)
Alzheimer's disease (1436)
Antibody-drug conjugate (ADC) (128)
Approvals (17276)
Artificial intelligence (248)
Autoimmune disease (13)
Automation (14)
Bankruptcy (387)
Best Places to Work (12624)
BIOSECURE Act (21)
Biosimilars (105)
Biotechnology (437)
Bladder cancer (57)
Brain cancer (29)
Breast cancer (256)
Cancer (1952)
Cardiovascular disease (160)
Career advice (2687)
Career pathing (32)
CAR-T (152)
Cell therapy (420)
Cervical cancer (14)
Clinical research (68716)
Collaboration (770)
Compensation (427)
Complete response letters (29)
COVID-19 (2816)
CRISPR (39)
C-suite (203)
Cystic fibrosis (104)
Data (1807)
Decentralized trials (2)
Denatured (24)
Depression (46)
Diabetes (251)
Diagnostics (6835)
Digital health (18)
Diversity (7)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (118)
Drug shortages (33)
Duchenne muscular dystrophy (75)
Earnings (87375)
Editorial (38)
Employer branding (24)
Employer resources (157)
Events (120250)
Executive appointments (639)
FDA (18368)
Featured Employer (66)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (680)
Gene editing (102)
Generative AI (25)
Gene therapy (296)
GLP-1 (787)
Government (4907)
Grass and pollen (4)
Guidances (46)
Healthcare (20786)
Huntington's disease (24)
IgA nephropathy (23)
Immunology and inflammation (111)
Indications (24)
Infectious disease (2951)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (46)
Intellectual property (76)
Interviews (625)
IPO (17594)
IRA (49)
Job creations (4572)
Job search strategy (2217)
Kidney cancer (10)
Labor market (32)
Layoffs (523)
Leadership (19)
Legal (8738)
Liver cancer (76)
Lung cancer (286)
Lymphoma (127)
Machine learning (2)
Management (62)
Manufacturing (280)
MASH (62)
Medical device (14496)
Medtech (14501)
Mergers & acquisitions (21009)
Metabolic disorders (673)
Multiple sclerosis (67)
NASH (23)
Neurodegenerative disease (89)
Neuropsychiatric disorders (29)
Neuroscience (1927)
NextGen: Class of 2025 (7574)
Non-profit (5050)
Northern California (2307)
Now hiring (37)
Obesity (370)
Opinion (261)
Ovarian cancer (64)
Pain (82)
Pancreatic cancer (73)
Parkinson's disease (129)
Partnered (18)
Patents (196)
Patient recruitment (86)
Peanut (50)
People (61769)
Pharmaceutical (132)
Pharmacy benefit managers (21)
Phase I (21294)
Phase II (30221)
Phase III (22760)
Pipeline (863)
Podcasts (96)
Policy (125)
Postmarket research (2732)
Preclinical (8978)
Press Release (72)
Prostate cancer (91)
Psychedelics (38)
Radiopharmaceuticals (264)
Rare diseases (383)
Real estate (6667)
Recruiting (72)
Regulatory (24252)
Reports (42)
Research institute (2611)
Resumes & cover letters (507)
Rett syndrome (3)
RNA editing (2)
RSV (45)
Schizophrenia (72)
Series A (125)
Series B (73)
Service/supplier (26)
Sickle cell disease (55)
Southern California (1998)
Special edition (18)
Sponsored (33)
Startups (4086)
State (2)
Stomach cancer (15)
Supply chain (64)
The Weekly (71)
United States (21096)
Vaccines (738)
Venture capitalists (36)
Webinars (13)
Weight loss (277)
Women's health (31)
Worklife (17)
Date
Today (89)
Last 7 days (650)
Last 30 days (3059)
Last 365 days (36480)
2025 (6593)
2024 (37774)
2023 (42553)
2022 (53891)
2021 (58677)
2020 (57557)
2019 (51190)
2018 (38962)
2017 (35838)
2016 (35866)
2015 (41632)
2014 (34605)
2013 (29503)
2012 (31128)
2011 (31665)
2010 (29302)
Location
Africa (972)
Alabama (55)
Alaska (7)
Arizona (197)
Arkansas (13)
Asia (44569)
Australia (7508)
California (5396)
Canada (1820)
China (448)
Colorado (248)
Connecticut (272)
Delaware (123)
Europe (99692)
Florida (785)
Georgia (189)
Hawaii (1)
Idaho (63)
Illinois (527)
India (25)
Indiana (301)
Iowa (8)
Japan (133)
Kansas (104)
Kentucky (27)
Louisiana (11)
Maine (68)
Maryland (853)
Massachusetts (4216)
Michigan (228)
Minnesota (376)
Mississippi (2)
Missouri (82)
Montana (31)
Nebraska (26)
Nevada (56)
New Hampshire (66)
New Jersey (1540)
New Mexico (30)
New York (1530)
North Carolina (1024)
North Dakota (8)
Northern California (2307)
Ohio (194)
Oklahoma (14)
Oregon (44)
Pennsylvania (1202)
Puerto Rico (7)
Rhode Island (27)
South America (1366)
South Carolina (16)
South Dakota (1)
Southern California (1998)
Tennessee (88)
Texas (801)
Utah (165)
Virginia (140)
Washington D.C. (64)
Washington State (533)
West Virginia (3)
Wisconsin (55)
752,116 Results for "dotmed com".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Antibodies.com and Cactus Communications Partner to Accelerate Life Science Manuscript Publication
February 6, 2025
·
2 min read
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
Compugen Ltd. today announced that it will present new clinical data on COM701 (anti-PVRIG) in triple combination with COM902 (anti-TIGIT) and pembrolizumab in microsatellite stable colorectal cancer at the American Society of Clinical Oncology (ASCO) annual meeting on May31-June 4 2023, in Chicago, Illinois.
April 25, 2024
·
2 min read
Pharm Country
DOTmed.com Introduces Free COVID-19 Equipment Redeployment Program for Hospitals
DOTmed.com, the world’s leading online medical equipment marketplace, is launching a free service to help hospitals across the country support one another in their efforts to combat the novel coronavirus.
April 2, 2020
·
2 min read
Biotech Beach
Sanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com’s Supplier Pre-assessment Program
Sanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i ® , Scientist.com’s Supplier Pre-assessment Program.
April 9, 2024
·
3 min read
Business
Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com
Halberd Corporation (OTC PINK:HALB) and CrodenHealth.com of Canada agree to produce, market, sell and distribute Halberd’s patented low dose naltrexone combo product(s) worldwide.
December 13, 2023
·
4 min read
OrganaBio Approved as A Science Exchange and Scientist.com Partner
OrganaBio products and services can now be accessed via the Science Exchange and Scientist.com platforms.
September 18, 2023
·
2 min read
Client Success Stories: How MedicalLicensing.com Transformed the Licensing Journeys of Top Medical Professionals
Discover how MedicalLicensing.com has revolutionized the medical licensing process for top healthcare professionals and businesses.
October 3, 2023
·
5 min read
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
Compugen Ltd. announced the simultaneous online publication of a peer reviewed paper titled ‘Unleashing natural IL-18 activity using an anti-IL-18BP blocker antibody induces potent immune stimulation and anti-tumor effects’ link, in Cancer Immunology Research, a journal of the American Association for Cancer Research with a presentation at the American Association for Cancer Research annual meeting on April 5-11, 2024, in San Diego, California.
April 10, 2024
·
5 min read
Compugen Doses First Patient in Triple Immunotherapy Combination COM701, COM902 and Pembrolizumab Platinum Resistant Ovarian Cancer Proof-of-Concept Study
Compugen Ltd. today announced that the first patient has been dosed in the triple immunotherapy combination proof-of-concept study evaluating COM701, Compugen’s potential first-in-class anti-PVRIG antibody, with COM902, Compugen’s potential best-in-class anti-TIGIT antibody and pembrolizumab in patients with platinum resistant ovarian cancer.
June 22, 2023
·
6 min read
1 of 75,212
Next
